{
    "data": [
        {
            "id": "urn:summary_document_slides:quartr.com:2939648:0",
            "title": "TKNO: 2025 revenue rose 7% to $40.5M, with 2026 guidance for continued growth and improved cash flow",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>2025 revenue grew 7% to $40.5M, with strong Q4 growth in Clinical Solutions and improved gross margin. 2026 guidance targets 6% revenue growth and reduced cash outflow, with break-even Adjusted EBITDA expected by end of 2027.</span></p><p class=\"\"><span>Original document: </span><a class=\"link-zw5jRdec\" href=\"https://www.tradingview.com/accounts/signin?next=https%3A%2F%2Fnews-mediator.tradingview.com%2Fdoc-screener%2Fv1%2Ffiles%2Furn%3Aslides%3Aquartr.com%3A2939648-c3c8fed6dd505c3020431174a93d7b5b\" target=\"_blank\">Alpha Teknova, Inc. [TKNO] Slides Release â€” Feb. 26 2026</a></p><section class=\"variant-secondary-aHOVUrmQ disclaimer-fdvjGD1u\"><b class=\"heading-wrapper-aHOVUrmQ\"><span class=\"heading-aHOVUrmQ\">Disclaimer</span></b><div class=\"content-aHOVUrmQ link-with-underline-aHOVUrmQ\"><span>This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.</span></div></section></span></div></div>",
            "link": "https://www.tradingview.com/news/urn:summary_document_slides:quartr.com:2939648:0-tkno-2025-revenue-rose-7-to-40-5m-with-2026-guidance-for-continued-growth-and-improved-cash-flow/",
            "pub_date": "2026-02-27 05:54:18",
            "source": "Quartr",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226015756_20260226017812:0",
            "title": "Rocket Lab: Newly Acquired Facility Will Be Established as Auckland Machine Complex >RKLB",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span class=\"placeholder-diQOvrPB\">This news item displays a headline only and has no other text.</span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226015756_20260226017812:0/",
            "pub_date": "2026-02-27 05:55:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226017817_20260226017817:0",
            "title": "Monash IVF Price Target Cut 5.3% to A$0.90/Share by Ord Minnett",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span class=\"placeholder-diQOvrPB\">This news item displays a headline only and has no other text.</span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226017817_20260226017817:0/",
            "pub_date": "2026-02-27 05:55:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_SN20260226018435:0",
            "title": "CoreWeave's stock drops as losses swell and interest expenses climb",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>By Christine Ji</span></p><p class=\"\"><span>While AI demand remains high, CoreWeave's widening net loss in the fourth quarter is giving investors pause</span></p><p class=\"\"><span>CoreWeave's revenue backlog quadrupled from the beginning of 2025.</span></p><p class=\"\"><span>CoreWeave shares faced pressure in after-hours trading on Thursday after the company's fourth-quarter earnings report showed healthy demand and revenue growth but a widening net loss.</span></p><p class=\"\"><span>CoreWeave's stock (CRWV) was down about 6% after the closing bell. The company's fourth-quarter revenue reached $1.57 billion, growing 110% year over year and exceeding the $1.55 billion FactSet consensus. The company posted a net loss of $452 million, far steeper than the $342 million anticipated by analysts.</span></p><p class=\"\"><span>\"2025 was a defining year for CoreWeave as we became the fastest cloud in history to reach $5 billion in annual revenue,\" chair and CEO Michael Intrator said in the press release.</span></p><p class=\"\"><span>Demand for CoreWeave's products is strong. The company's backlog grew to $66.8 billion in the fourth quarter - quadrupling from the beginning of 2025 - and CoreWeave is building aggressively to turn the backlog into revenue. The company added 260 megawatts of active power capacity in the fourth quarter alone, bringing its total to over 850 megawatts. More important for future scaling, CoreWeave has contracted for 3.1 gigawatts of total power, securing access to address a critical artificial-intelligence bottleneck.</span></p><p class=\"\"><span>But the cost of building the massive data centers required to house Nvidia's (NVDA) high-end chips continues to weigh on the bottom line, especially as CoreWeave takes on debt to fund its expansion. While CoreWeave is growing revenues at a rapid clip, the company's interest expenses are increasing at a similar pace. Net interest expense for the fourth quarter was $388 million, a 160% year-over-year increase. For 2025, net interest expense came out to $1.23 billion, a 240% year-over-year increase.</span></p><p class=\"\"><span>CoreWeave reported a full-year net loss of $1.17 billion, compared with a loss of $863 million the previous year.</span></p><p class=\"\"><span>Read: Here's what CoreWeave's earnings need to show for the stock to soar further</span></p><p class=\"\"><span>-Christine Ji</span></p><p class=\"\"><span>This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_SN20260226018435:0/",
            "pub_date": "2026-02-27 05:55:00",
            "source": "MarketWatch",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226014512_20260226017819:0",
            "title": "BioLife Solutions 4Q Rev $24.8M",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span class=\"placeholder-diQOvrPB\">This news item displays a headline only and has no other text.</span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226014512_20260226017819:0/",
            "pub_date": "2026-02-27 05:55:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226014512_20260226017810:0",
            "title": "BioLife Solutions 4Q EPS 4c",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span class=\"placeholder-diQOvrPB\">This news item displays a headline only and has no other text.</span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226014512_20260226017810:0/",
            "pub_date": "2026-02-27 05:55:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226017763_20260226017815:0",
            "title": "AML3D Had A$29.2M Cash at Bank at Dec 31>AL3.AU",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span class=\"placeholder-diQOvrPB\">This news item displays a headline only and has no other text.</span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226017763_20260226017815:0/",
            "pub_date": "2026-02-27 05:55:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026:newsml_L1N3ZM1HU:0",
            "title": "SITE Centers posts Q4 net income on gains from property sales",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Overview</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Shopping center owner's Q4 net income rose to $134.4 mln from loss last year</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Operating FFO for Q4 fell due to lower NOI from property dispositions</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Company sold eight properties for $380 mln, repaid $187 mln mortgage debt</span></p></li></ul><p class=\"\"><span>Outlook</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Company maintains higher cash balance to maximize joint venture monetization options</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>SITE Centers continues to sell remaining retail real estate assets</span></p></li></ul><p class=\"\"><span>Result Drivers</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>PROPERTY SALES - Gains from property sales significantly boosted net income, while lower NOI from these sales impacted Operating FFO</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>DEBT REPAYMENT - Reduced interest expenses contributed to higher net income, as the company repaid $187 mln in mortgage debt</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>LEASED RATE DECLINE - Leased rate fell due to transactional activity and increased vacancy at The Maxwell, affecting occupancy metrics</span></p></li></ul><p class=\"\"><span>Company press release: </span></p><p class=\"\"><span>Key Details</span></p><div class=\"tableContainer-VG8_37yK\"><table class=\"table-VG8_37yK\" data-no-swipe=\"true\"><tbody><tr><td><p class=\"\"><span>Metric</span></p></td><td><p class=\"\"><span>Beat/Miss</span></p></td><td><p class=\"\"><span>Actual</span></p></td><td><p class=\"\"><span>Consensus Estimate</span></p></td></tr><tr><td><p class=\"\"><span>Q4 EPS</span></p></td><td></td><td><p class=\"\"><span>$2.55</span></p></td><td></td></tr><tr><td><p class=\"\"><span>Q4 Net Income</span></p></td><td></td><td><p class=\"\"><span>$134.40 mln</span></p></td><td></td></tr><tr><td><p class=\"\"><span>Q4 FFO</span></p></td><td></td><td><p class=\"\"><span>$2.90 mln</span></p></td><td></td></tr></tbody></table></div><p class=\"\"><span>Analyst Coverage</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The current average analyst rating on the shares is \"hold\" and the breakdown of recommendations is 1 \"strong buy\" or \"buy\", 3 \"hold\" and no \"sell\" or \"strong sell\"</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The average consensus recommendation for the commercial reits peer group is \"buy.\"</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Wall Street's median 12-month price target for Site Centers Corp is $8.00, about 20.5% above its February 25 closing price of $6.64</span></p></li></ul><p class=\"\"><span>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact </span><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"http://mailto:reuters.support@thomsonreuters.com\" rel=\"nofollow\" target=\"_blank\">reuters.support@thomsonreuters.com</a><span>.</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026:newsml_L1N3ZM1HU:0-site-centers-posts-q4-net-income-on-gains-from-property-sales/",
            "pub_date": "2026-02-27 05:55:31",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026-02-26:newsml_ACSxqc35a:0",
            "title": "Tecogen Schedules Earnings Release Date and Conference Call For FY 2025 Results",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>BILLERICA, MA / ACCESS Newswire / February 26, 2026 / Tecogen Inc. (NYSE American:TGEN) will release FY 2025 financial results on Wednesday, March 18th. The earnings press release and supplemental earnings presentation will be available on the Company's website at www.Tecogen.com in the \"Investor Relations\" section under \"Financial Results.\" Members of Tecogen's senior management will hold a conference call and webcast on Wednesday, March 18th at 9:30 AM Eastern Time to discuss the Company's financial performance for FY 2025.</span></p><p class=\"\"><span>The conference call will be available live via telephone and webcast. To listen to the audio portion, dial 877-407-7186 within the US and Canada or 201-689-8052 from other international locations. Participants should ask to join the Tecogen earnings call. Please begin dialing at least 10 minutes before the scheduled starting time. Alternately, to register for and listen to the webcast, go to Webcast.</span></p><p class=\"\"><span>The earnings conference call will be recorded and available for playback one hour after the end of the call. To listen to the playback dial (877) 660-6853 within the US and Canada or (201) 612-7415 from other international locations. Use Access ID #: 13752231. The webcast will be archived for 14 days following the call.</span></p><p class=\"\"><strong class=\"root-Tkn6WL2y\"><span>About Tecogen</span></strong></p><p class=\"\"><span>Tecogen designs, manufactures, sells, installs, and maintains high efficiency, ultra-clean, cogeneration products including engine-driven combined heat and power, air conditioning systems, and high-efficiency water heaters for residential, commercial, recreational and industrial use. The company provides cost effective, environmentally friendly and reliable products for energy production that nearly eliminate criteria pollutants and significantly reduce a customer's carbon footprint. In business for over 35 years, Tecogen has shipped more than 3,200 units, supported by an established network of engineering, sales, and service personnel in key markets in North America. For more information, please visit www.tecogen.com or contact us for a free Site Assessment.</span></p><p class=\"\"><strong class=\"root-Tkn6WL2y\"><span>Forward Looking Statements</span></strong></p><p class=\"\"><span>This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995 and other federal securities laws that involve a number of risks and uncertainties. Forward-looking statements generally can be identified by the use of forward-looking terminology such as </span><span>\"believe,\" \"expect,\" \"anticipate,\" \"intend,\" \"plan,\" \"estimate,\" \"project,\" \"target,\" \"potential,\" \"will,\" \"should,\" \"seek,\" \"could,\" \"likely,\" \"may,\" \"pro forma,\" \"anticipate,\" \"continue,\" or other variations thereof (including their use in the negative), or by discussions of strategies, plans or intentions. All statements, other than statements of historical fact included in this press release regarding our strategy, future operations, future financial position, future revenues, projected costs, prospects and plans and objectives of management are forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors that may cause our actual results to differ materially from those expressed or implied by such forward-looking statements. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Forward-looking statements speak only as of the date on which they are made, and we undertake no obligation to update or revise any forward-looking statements.</span></p><p class=\"\"><span>In addition to those factors described in our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q and in our Form 8-K, under \"Risk Factors,\" among the factors that could cause actual results to differ materially from past and projected future results are the following: fluctuations in demand for our products and services, competing technological developments, issues relating to research and development, the availability of incentives, rebates, and tax benefits relating to our products and services, changes in the regulatory environment relating to our products and services, integration of acquired business operations, and the ability to obtain financing on favorable terms to fund existing operations and anticipated growth.</span></p><p class=\"\"><span>Tecogen Media &amp; Investor Relations Contact Information:</span></p><p class=\"\"><span>Abinand Rangesh, CEO</span></p><p class=\"\"><span>P: 781-466-6487</span></p><p class=\"\"><span>E: Abinand.Rangesh@tecogen.com</span></p><p class=\"\"><strong class=\"root-Tkn6WL2y\"><span>SOURCE:</span></strong><span> Tecogen, Inc.</span></p><p class=\"\"><span>View the original press release on ACCESS Newswire</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026-02-26:newsml_ACSxqc35a:0/",
            "pub_date": "2026-02-27 05:55:46",
            "source": "Acceswire",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_SN20260226018445:0",
            "title": "U.S.-Iran nuclear talks end, but with hope that negotiations continue. That still leaves the oil market in limbo.",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>By Myra P. Saefong</span></p><p class=\"\"><span>Oman's foreign minister, a meditator of the U.S.-Iran talks, indicated Thursday that the two sides had made progress and would resume negotiations at another time</span></p><p class=\"\"><span>The U.S. and Iran wrapped up Thursday's negotiations after \"significant progress,\" Oman's foreign minister posted on social media.</span></p><p class=\"\"><span>Growing tensions between the U.S. and Iran have kept the oil market on edge for much of this year, as President Donald Trump threatened military action if the two nations failed to reach a deal to put an end to Tehran's nuclear ambitions.</span></p><p class=\"\"><span>Nuclear talks on Thursday were expected to ease much of the uncertainty surrounding those tensions. The talks apparently ended \"after significant progress\" in negotiations, said Badr Albusaidi, Oman's foreign minister, in a post on X. Oman mediated the negotiations in Geneva.</span></p><p class=\"\"><span>Albusaidi offered no details on those negotiations, but said in his post that talks would resume after \"consultation in the respective capitals.\" He also said discussions on a \"technical level\" would take place next week in Vienna.</span></p><p class=\"\"><span>The White House didn't immediately respond to an emailed request from MarketWatch for details on the outcome of Thursday's negotiations.</span></p><p class=\"\"><span>The news left oil prices slightly lower on Thursday, with April West Texas Intermediate crude (CLJ26) (CL.1) down 0.3% to settle at $65.21 a barrel, and April Brent crude (BRNJ26) at $70.75, down 0.1% for the session.</span></p><p class=\"\"><span>\"Geopolitics will drive the market in the short term, with prices rising and falling based on talks and then likely military actions,\" said Matt Gertken, chief geopolitical strategist at BCA Research. \"Only after there is a diplomatic or military resolution will fundamentals reassert themselves.\"</span></p><p class=\"\"><span>Following Thursday's talks, \"there may only be one more chance for diplomacy to avoid a military confrontation next week,\" Gertken told MarketWatch.</span></p><p class=\"\"><span>\"If Iran is not willing to renounce all uranium enrichment on its soil permanently, then the U.S. will likely take another round of military action against Iran's nuclear and ballistic missile programs,\" he said. Last June, during the Israel-Iran war, the U.S. military attacked three Iranian nuclear facilities.</span></p><p class=\"\"><span>Gertken suggested that the March 2-6 meeting of the International Atomic Energy Agency, and potential secret talks in the aftermath, may be the last opportunity for Iran to \"capitulate prior to the U.S. taking military action.\"</span></p><p class=\"\"><span>Trump has said that U.S. military has amassed an armada of warships and fighter jets near Iran.</span></p><p class=\"\"><span>Oil may see active buying until Trump's deadline of March 6, said Gertken. That's when Trump has said he expects to decide his next move on Iran.</span></p><p class=\"\"><span>Robert Schroeder contributed.</span></p><p class=\"\"><span>-Myra P. Saefong</span></p><p class=\"\"><span>This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_SN20260226018445:0/",
            "pub_date": "2026-02-27 05:56:00",
            "source": "MarketWatch",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226017009_20260226017833:0",
            "title": "Proficient Auto Logistics Names Rohit Lal to Board",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span class=\"placeholder-diQOvrPB\">This news item displays a headline only and has no other text.</span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226017009_20260226017833:0/",
            "pub_date": "2026-02-27 05:56:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026:newsml_L1N3ZM1HP:0",
            "title": "SoundHound AI Q4 revenue jumps 59% on strong enterprise AI demand, new partnerships",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Overview</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Voice AI firm's Q4 revenue rose 59% yr/yr, driven by strong customer demand</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Full year revenue slightly beat analyst expectations</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Adjusted EBITDA for the year missed analyst estimates</span></p></li></ul><p class=\"\"><span>Outlook</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>SoundHound expects 2026 revenue between $225 mln and $260 mln</span></p></li></ul><p class=\"\"><span>Result Drivers</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>ENTERPRISE AI DEMAND - CEO Keyvan Mohajer attributed strong Q4 results to increased demand for enterprise-grade AI solutions</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>AUTOMOTIVE PARTNERSHIPS - SoundHound expanded its reach in the automotive sector with new OEM deals in Japan, Korea, and Europe</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>VOICE COMMERCE EXPANSION - The company expanded its voice commerce capabilities, signing deals with a global automaker and a smart TV manufacturer</span></p></li></ul><p class=\"\"><span>Company press release: </span></p><p class=\"\"><span>Key Details</span></p><div class=\"tableContainer-VG8_37yK\"><table class=\"table-VG8_37yK\" data-no-swipe=\"true\"><tbody><tr><td><p class=\"\"><span>Metric</span></p></td><td><p class=\"\"><span>Beat/Miss</span></p></td><td><p class=\"\"><span>Actual</span></p></td><td><p class=\"\"><span>Consensus Estimate</span></p></td></tr><tr><td><p class=\"\"><span>Q4 Revenue</span></p></td><td></td><td><p class=\"\"><span>$55.1 mln</span></p></td><td></td></tr><tr><td><p class=\"\"><span>FY Revenue</span></p></td><td><p class=\"\"><span>Slight Beat*</span></p></td><td><p class=\"\"><span>$169 mln</span></p></td><td><p class=\"\"><span>$167.84 mln (9 Analysts)</span></p></td></tr><tr><td><p class=\"\"><span>FY EPS</span></p></td><td></td><td><p class=\"\"><span>-$0.03</span></p></td><td></td></tr><tr><td><p class=\"\"><span>FY Net Income</span></p></td><td></td><td><p class=\"\"><span>-$14 mln</span></p></td><td></td></tr><tr><td><p class=\"\"><span>FY Adjusted EBITDA</span></p></td><td><p class=\"\"><span>Miss</span></p></td><td><p class=\"\"><span>-$58.40 mln</span></p></td><td><p class=\"\"><span>-$55.10 mln (8 Analysts)</span></p></td></tr></tbody></table></div><p class=\"\"><span>*Applies to a deviation of less than 1%; not applicable for per-share numbers.</span></p><p class=\"\"><span>Analyst Coverage</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 7 \"strong buy\" or \"buy\", 2 \"hold\" and no \"sell\" or \"strong sell\"</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The average consensus recommendation for the it services &amp; consulting peer group is \"buy\"</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Wall Street's median 12-month price target for SoundHound AI Inc is $15.75, about 84.9% above its February 25 closing price of $8.52</span></p></li></ul><p class=\"\"><span>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact </span><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"http://mailto:reuters.support@thomsonreuters.com\" rel=\"nofollow\" target=\"_blank\">reuters.support@thomsonreuters.com</a><span>.</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026:newsml_L1N3ZM1HP:0-soundhound-ai-q4-revenue-jumps-59-on-strong-enterprise-ai-demand-new-partnerships/",
            "pub_date": "2026-02-27 05:56:04",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026:newsml_L1N3ZM1HO:0",
            "title": "Ambarella Q4 revenue rises",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Overview</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Edge AI semiconductor firm's Q4 revenue rose 20.1% yr/yr, slightly beating analyst expectations</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Company reported Q4 GAAP net loss of $16.4 mln, improving from prior yr loss</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Non-GAAP net profit for Q4 was $5.5 mln, up from $4.8 mln last year</span></p></li></ul><p class=\"\"><span>Outlook</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Ambarella expects Q1 fiscal 2027 revenue between $97.0 mln and $103.0 mln</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Company anticipates full-year fiscal 2027 revenue growth of 10% to 15%</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Ambarella expects Q1 non-GAAP gross margin between 59.0% and 60.5%</span></p></li></ul><p class=\"\"><span>Result Drivers</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>EDGE AI SOCS - Edge AI SoCs represented 80% of revenue, driving significant growth, according to CEO Fermi Wang</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>PRODUCT EXPANSION - Co continues to build on edge AI leadership with new products and sales channels, per CEO Fermi Wang</span></p></li></ul><p class=\"\"><span>Company press release: </span></p><p class=\"\"><span>Key Details</span></p><div class=\"tableContainer-VG8_37yK\"><table class=\"table-VG8_37yK\" data-no-swipe=\"true\"><tbody><tr><td><p class=\"\"><span>Metric</span></p></td><td><p class=\"\"><span>Beat/Miss</span></p></td><td><p class=\"\"><span>Actual</span></p></td><td><p class=\"\"><span>Consensus Estimate</span></p></td></tr><tr><td><p class=\"\"><span>Q4 Revenue</span></p></td><td><p class=\"\"><span>Slight Beat*</span></p></td><td><p class=\"\"><span>$100.87 mln</span></p></td><td><p class=\"\"><span>$100.18 mln (11 Analysts)</span></p></td></tr><tr><td><p class=\"\"><span>Q4 Net Income</span></p></td><td></td><td><p class=\"\"><span>-$16.4 mln</span></p></td><td></td></tr><tr><td><p class=\"\"><span>Q4 Gross Profit</span></p></td><td></td><td><p class=\"\"><span>$58.91 mln</span></p></td><td></td></tr><tr><td><p class=\"\"><span>Q4 Income from Operations</span></p></td><td></td><td><p class=\"\"><span>-$18.43 mln</span></p></td><td></td></tr><tr><td><p class=\"\"><span>Q4 Pretax Profit</span></p></td><td></td><td><p class=\"\"><span>-$16.10 mln</span></p></td><td></td></tr></tbody></table></div><p class=\"\"><span>*Applies to a deviation of less than 1%; not applicable for per-share numbers.</span></p><p class=\"\"><span>Analyst Coverage</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 9 \"strong buy\" or \"buy\", 6 \"hold\" and no \"sell\" or \"strong sell\"</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The average consensus recommendation for the semiconductors peer group is \"buy\"</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Wall Street's median 12-month price target for Ambarella Inc is $100.00, about 42.3% above its February 25 closing price of $70.29</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The stock recently traded at 114 times the next 12-month earnings vs. a P/E of 170 three months ago</span></p></li></ul><p class=\"\"><span>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact </span><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"http://mailto:reuters.support@thomsonreuters.com\" rel=\"nofollow\" target=\"_blank\">reuters.support@thomsonreuters.com</a><span>.</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026:newsml_L1N3ZM1HO:0-ambarella-q4-revenue-rises/",
            "pub_date": "2026-02-27 05:56:28",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026:newsml_L4N3ZM2GK:0",
            "title": "Virgin Australia half-year profit tops estimate on strong holiday demand",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Virgin Australia </span><span> posted a 20.7% rise in half-year underlying profit on Friday, beating estimates as strong customer demand and benefits from its transformation program lifted the bottom line.</span></p><p class=\"\"><span>Australia's second-largest airline reported underlying net profit after tax of A$278.7 million ($198.07 million) for the six months ended December 31, beating Visible Alpha's consensus estimate of A$261.1 million and up from A$230.9 million a year earlier.</span></p><p class=\"\"><span>Strong domestic demand during the holiday season lifted the company's airline business, while progress in the group's transformation program delivered more than A$200 million in gross benefits.</span></p><p class=\"\"><span>Launched after Virgin Australia exited voluntary administration, the program aims to modernise outdated technology and systems, streamline processes, reorganise the business for efficiency and simplify its fleet.</span></p><p class=\"\"><span>($1 = 1.4071 Australian dollars)</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026:newsml_L4N3ZM2GK:0-virgin-australia-half-year-profit-tops-estimate-on-strong-holiday-demand/",
            "pub_date": "2026-02-27 05:48:14",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026:newsml_L1N3ZM1GU:0",
            "title": "Fintech platform Rocket Companies beats Q4 adjusted revenue expectations",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Overview</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Homeownership platform's Q4 adjusted revenue beat analyst expectations</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Adjusted EPS for Q4 beat analyst expectations</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Company announced strategic alliance with Compass to expand housing inventory</span></p></li></ul><p class=\"\"><span>Outlook</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Rocket Companies expects Q1 2026 adjusted revenue between $2.6 bln and $2.8 bln</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Company will reclassify warehouse interest on loans held for sale starting Q1 2026</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Rocket Companies announces strategic alliance with Compass to expand housing inventory</span></p></li></ul><p class=\"\"><span>Result Drivers</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>TECHNOLOGICAL ADVANCEMENTS - Launch of fully digital purchase pre-approvals increased conversion rates, supporting growth in mortgage origination</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>ACQUISITION INTEGRATION - Successful integration of Redfin and Mr. Cooper acquisitions realized significant cost synergies and expanded digital capabilities</span></p></li></ul><p class=\"\"><span>Company press release: </span></p><p class=\"\"><span>Key Details</span></p><div class=\"tableContainer-VG8_37yK\"><table class=\"table-VG8_37yK\" data-no-swipe=\"true\"><tbody><tr><td><p class=\"\"><span>Metric</span></p></td><td><p class=\"\"><span>Beat/Miss</span></p></td><td><p class=\"\"><span>Actual</span></p></td><td><p class=\"\"><span>Consensus Estimate</span></p></td></tr><tr><td><p class=\"\"><span>Q4 Revenue</span></p></td><td></td><td><p class=\"\"><span>$2.69 bln</span></p></td><td></td></tr><tr><td><p class=\"\"><span>Q4 Adjusted Revenue</span></p></td><td><p class=\"\"><span>Beat</span></p></td><td><p class=\"\"><span>$2.44 bln</span></p></td><td><p class=\"\"><span>$2.26 bln (10 Analysts)</span></p></td></tr><tr><td><p class=\"\"><span>Q4 Adjusted EPS</span></p></td><td><p class=\"\"><span>Beat</span></p></td><td><p class=\"\"><span>$0.11</span></p></td><td><p class=\"\"><span>$0.09 (12 Analysts)</span></p></td></tr><tr><td><p class=\"\"><span>Q4 Adjusted Net Income</span></p></td><td></td><td><p class=\"\"><span>$316 mln</span></p></td><td></td></tr><tr><td><p class=\"\"><span>Q4 Net Income</span></p></td><td></td><td><p class=\"\"><span>$68 mln</span></p></td><td></td></tr></tbody></table></div><p class=\"\"><span>Analyst Coverage</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 5 \"strong buy\" or \"buy\", 10 \"hold\" and no \"sell\" or \"strong sell\"</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The average consensus recommendation for the financial technology (fintech) peer group is \"buy\"</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Wall Street's median 12-month price target for Rocket Companies Inc is $22.00, about 26.9% above its February 25 closing price of $17.33</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The stock recently traded at 21 times the next 12-month earnings vs. a P/E of 24 three months ago</span></p></li></ul><p class=\"\"><span>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact </span><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"http://mailto:reuters.support@thomsonreuters.com\" rel=\"nofollow\" target=\"_blank\">reuters.support@thomsonreuters.com</a><span>.</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026:newsml_L1N3ZM1GU:0-fintech-platform-rocket-companies-beats-q4-adjusted-revenue-expectations/",
            "pub_date": "2026-02-27 05:48:23",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026:newsml_L1N3ZM1H3:0",
            "title": "Amphastar Q4 revenue misses estimates",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Overview</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Biopharmaceutical firm's Q4 revenue miss analyst expectations</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Adjusted EPS for Q4 missed analyst expectations</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>BAQSIMI sales increased due to higher unit volumes from U.S. marketing efforts</span></p></li></ul><p class=\"\"><span>Outlook</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Amphastar to scale U.S. manufacturing for growth phase</span></p></li></ul><p class=\"\"><span>Result Drivers</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>BAQSIMI SALES - Increased due to higher unit volumes from U.S. marketing efforts</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>GLUCAGON SALES DECLINE - Decreased due to lower pricing and unit volumes amid competition</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>NEW PRODUCT LAUNCHES - Iron sucrose and other products contributed to revenue</span></p></li></ul><p class=\"\"><span>Company press release: </span></p><p class=\"\"><span>Key Details</span></p><div class=\"tableContainer-VG8_37yK\"><table class=\"table-VG8_37yK\" data-no-swipe=\"true\"><tbody><tr><td><p class=\"\"><span>Metric</span></p></td><td><p class=\"\"><span>Beat/Miss</span></p></td><td><p class=\"\"><span>Actual</span></p></td><td><p class=\"\"><span>Consensus Estimate</span></p></td></tr><tr><td><p class=\"\"><span>Q4 Revenue</span></p></td><td><p class=\"\"><span>Miss</span></p></td><td><p class=\"\"><span>$183.11 mln</span></p></td><td><p class=\"\"><span>$190.48 mln (6 Analysts)</span></p></td></tr><tr><td><p class=\"\"><span>Q4 Adjusted EPS</span></p></td><td><p class=\"\"><span>Miss</span></p></td><td><p class=\"\"><span>$0.73</span></p></td><td><p class=\"\"><span>$0.92 (7 Analysts)</span></p></td></tr><tr><td><p class=\"\"><span>Q4 EPS</span></p></td><td></td><td><p class=\"\"><span>$0.51</span></p></td><td></td></tr><tr><td><p class=\"\"><span>Q4 Adjusted Net Income</span></p></td><td><p class=\"\"><span>Miss</span></p></td><td><p class=\"\"><span>$34.16 mln</span></p></td><td><p class=\"\"><span>$43.60 mln (6 Analysts)</span></p></td></tr><tr><td><p class=\"\"><span>Q4 Net Income</span></p></td><td></td><td><p class=\"\"><span>$24.43 mln</span></p></td><td></td></tr></tbody></table></div><p class=\"\"><span>Analyst Coverage</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 3 \"strong buy\" or \"buy\", 3 \"hold\" and no \"sell\" or \"strong sell\"</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The average consensus recommendation for the pharmaceuticals peer group is \"buy\"</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Wall Street's median 12-month price target for Amphastar Pharmaceuticals Inc is $30.00, about 7.3% above its February 25 closing price of $27.97</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The stock recently traded at 8 times the next 12-month earnings vs. a P/E of 7 three months ago</span></p></li></ul><p class=\"\"><span>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact </span><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"http://mailto:reuters.support@thomsonreuters.com\" rel=\"nofollow\" target=\"_blank\">reuters.support@thomsonreuters.com</a><span>.</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026:newsml_L1N3ZM1H3:0-amphastar-q4-revenue-misses-estimates/",
            "pub_date": "2026-02-27 05:48:29",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "urn:summary_document_transcript:quartr.com:2939641:0",
            "title": "Korea Electric Power: 2025 saw higher profits on increased power sales and lower fuel costs, with nuclear's share set to rise",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Operating and net income improved year-over-year, driven by higher power sales and lower fuel costs. Nuclear and coal generation mix is shifting, with nuclear's share set to rise in 2026. Dividend payout ratio fell, but DPS increased due to higher net income.</span></p><p class=\"\"><span>Based on </span></p><section class=\"variant-secondary-aHOVUrmQ disclaimer-fdvjGD1u\"><b class=\"heading-wrapper-aHOVUrmQ\"><span class=\"heading-aHOVUrmQ\">Disclaimer</span></b><div class=\"content-aHOVUrmQ link-with-underline-aHOVUrmQ\"><span>This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.</span></div></section></span></div></div>",
            "link": "https://www.tradingview.com/news/urn:summary_document_transcript:quartr.com:2939641:0-korea-electric-power-2025-saw-higher-profits-on-increased-power-sales-and-lower-fuel-costs-with-nuclear-s-share-set-to-rise/",
            "pub_date": "2026-02-27 05:48:37",
            "source": "Quartr",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "urn:summary_document_transcript:quartr.com:2939642:0",
            "title": "INMB: CORDStrom reduced itch and pain, improved healing, and showed strong safety in RDEB children",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Mission EB phase III trial showed CORDStrom, a pooled umbilical cord-derived cell therapy, significantly reduced itch and pain, improved wound healing, and was safe in children with RDEB. Sustained benefits were observed at six months, with the greatest impact in severe cases. Regulatory submissions are planned for 2024.</span></p><p class=\"\"><span>Based on </span></p><section class=\"variant-secondary-aHOVUrmQ disclaimer-fdvjGD1u\"><b class=\"heading-wrapper-aHOVUrmQ\"><span class=\"heading-aHOVUrmQ\">Disclaimer</span></b><div class=\"content-aHOVUrmQ link-with-underline-aHOVUrmQ\"><span>This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.</span></div></section></span></div></div>",
            "link": "https://www.tradingview.com/news/urn:summary_document_transcript:quartr.com:2939642:0-inmb-cordstrom-reduced-itch-and-pain-improved-healing-and-showed-strong-safety-in-rdeb-children/",
            "pub_date": "2026-02-27 05:48:38",
            "source": "Quartr",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226017679:0",
            "title": "MP Materials Revenue Falls After Halting Rare Earth Sales to China",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>By Katherine Hamilton</span></p><p class=\"\"><span>MP Materials posted lower revenue following its decision to cease rare earth sales to China as part of its agreement with the U.S. government.</span></p><p class=\"\"><span>The producer of rare earth minerals on Thursday posted a fourth-quarter profit of $9.4 million, or 5 cents a share, compared with a loss of $22.3 million, or 14 cents a share, a year earlier.</span></p><p class=\"\"><span>Stripping out certain one-time items, adjusted per-share earnings were 9 cents. Analysts polled by FactSet were expecting MP to break even on an adjusted basis.</span></p><p class=\"\"><span>Revenue fell 14% to $52.7 million, behind the $67.7 million analysts were forecasting.</span></p><p class=\"\"><span>Last July the Pentagon took a 15% stake in MP as part of a deal in which the company agreed to build a new factory to make rare-earth magnets.</span></p><p class=\"\"><span>To align with that agreement, MP ceased all sales to China, which resulted in no revenue recognized from rare earth concentrate during the quarter. That fueled the decline in revenue, MP said.</span></p><p class=\"\"><span>Chief Executive James Litinsky said the agreement with the government, along with a deal with Apple to deliver scaled recycling and magnetics capabilities, will help spur growth going forward.</span></p><p class=\"\"><span>The U.S. government is focused on increasing production of rare earth minerals, which are used in electric vehicles and smartphones, in an effort to remain competitive with China's production of the products.</span></p><p class=\"\"><span>Shares fell 4% to $57.40 in after-hours trading.</span></p><p class=\"\"><span>MP said earlier on Thursday that it would invest more than $1.25 billion in its large-scale rare-earth magnet manufacturing campus in Northlake, Texas. The investment would build onto its existing capacity in North Texas and is expected to come online in 2028.</span></p><p class=\"\"><span>Write to Katherine Hamilton at katherine.hamilton@wsj.com</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226017679:0/",
            "pub_date": "2026-02-27 05:49:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226013913_20260226017680:0",
            "title": "Data I/O Sees Organic Rev Growth for 2026 Over 2025 >DAIO",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span class=\"placeholder-diQOvrPB\">This news item displays a headline only and has no other text.</span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226013913_20260226017680:0/",
            "pub_date": "2026-02-27 05:49:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "DJN_DN20260226017069:0",
            "title": "Coles 1H Net Profit Falls 11% on Worker Remediation Costs",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><strong class=\"root-Tkn6WL2y\"><span>(21:31 GMT) </span></strong><span>*Coles 1H Net Profit A$511 Million, Down 11% on Year</span><br/><strong class=\"root-Tkn6WL2y\"><span>(21:31 GMT) </span></strong><span>*Coles 1H Underlying Net Profit A$676 Million, Up 13% on Year</span><br/><strong class=\"root-Tkn6WL2y\"><span>(21:32 GMT) </span></strong><span>*Coles 1H Ebit A$996 Million, Down 7.9% on Year</span><br/><strong class=\"root-Tkn6WL2y\"><span>(21:32 GMT) </span></strong><span>*Coles 1H Revenue A$23.69 Billion, Up 2.5% on Year</span><br/><strong class=\"root-Tkn6WL2y\"><span>(21:32 GMT) </span></strong><span>*Coles Interim Dividend A$0.41/Security</span><br/><strong class=\"root-Tkn6WL2y\"><span>(21:43 GMT) </span></strong><span>*Coles Says Supermarket Sales Revenue Up 3.7% in First Seven Weeks of 3Q</span><br/><strong class=\"root-Tkn6WL2y\"><span>(21:43 GMT) </span></strong><span>*Coles Says Supermarket Sales Revenue Up 5.3% in First Seven Weeks of 3Q When Tobacco Excluded</span><br/><strong class=\"root-Tkn6WL2y\"><span>(21:44 GMT) </span></strong><span>*Coles Says Supermarket Customers Remain Value Oriented</span><br/><strong class=\"root-Tkn6WL2y\"><span>(21:44 GMT) </span></strong><span>*Coles Expects Market to Remain Highly Competitive</span><br/><strong class=\"root-Tkn6WL2y\"><span>(21:44 GMT) </span></strong><span>*Coles Says Liquor Sales Fell 2.5% in First Seven Weeks of 3Q</span><br/><strong class=\"root-Tkn6WL2y\"><span>(21:45 GMT) </span></strong><span>*Coles Expects One-Off Costs of Around A$7 Million in 1H to Complete Simplification Process</span><br/><strong class=\"root-Tkn6WL2y\"><span>(21:49 GMT) </span></strong><span>Coles 1H Net Profit Falls 11% on Worker Remediation Costs</span></p><p class=\"\"><span>By David Winning</span></p><p class=\"\"><span>SYDNEY--Supermarket owner Coles said its half-year net profit fell by 11%, as the benefits of higher food sales were more than offset by a provision made to compensate workers who were underpaid some years ago.</span></p><p class=\"\"><span>Coles reported a net profit of 511 million Australian dollars (US$364.1 million) for the six months through December, down from A$576 million a year ago. Coles said it took an additional A$165 million post-tax provision to cover worker-remediation costs.</span></p><p class=\"\"><span>Revenue rose by 2.5% to A$23.69 billion, led by supermarket sales growth of 3.6% while liquor revenue was down by 3.2%.</span></p><p class=\"\"><span>On an underlying basis, which excludes significant items, Coles's half-year profit totaled A$676 million. That was up 13% on year, and was broadly in line with a consensus analyst forecast of A$674.4 million collated by Visible Alpha.</span></p><p class=\"\"><span>Directors of the company declared an interim dividend of 41 Australian cents a share, up from 37 cents a year ago.</span></p><p class=\"\"><span>Interest in Coles's result intensified after chief Australian rival Woolworths this week beat market expectations for its own earnings and outlook. Woolworths said trading since the start of January has been strong in Australian food, building on first-half sales growth of 3.6% in its biggest division. That prompted investment bank Jefferies to suggest the company has regained its sales leadership over Coles.</span></p><p class=\"\"><span>Coles also provided a trading update alongside its result on Friday. It said supermarket sales revenue rose by 3.7% in the first seven weeks of its fiscal third quarter, with growth higher at 5.3% when tobacco is excluded. Liquor sales fell by 2.5% in the same period.</span></p><p class=\"\"><span>Investors were alert to Coles choosing to step up promotional activity to beat back competition from Woolworths and watching for new signs that consumers are trading down to cheaper produce or shopping at discount food retailers to save money at a time when rising interest rates are rekindling cost-of-living concerns.</span></p><p class=\"\"><span>\"Customers remain value oriented and are responding well to our expanded range of everyday value products and loyalty offers,\" Coles said in its outlook commentary. \"We expect the market to remain highly competitive.\"</span></p><p class=\"\"><span>Write to David Winning at david.winning@wsj.com</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/DJN_DN20260226017069:0/",
            "pub_date": "2026-02-27 05:49:00",
            "source": "Dow Jones Newswires",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026:newsml_L1N3ZM1HX:0",
            "title": "PRA Group Q4 cash collections rise",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Overview</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Debt collector's Q4 cash collections rose 13.6% yr/yr, driven by U.S. and European markets</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Company repurchased $20 mln of shares in 2025 to drive shareholder value</span></p></li></ul><p class=\"\"><span>Outlook</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Company estimates forward flow commitments of $378 mln over next 12 months</span></p></li></ul><p class=\"\"><span>Result Drivers</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>CASH COLLECTIONS - Q4 cash collections rose 13.6% to $531.7 mln, driven by U.S. legal collections and strong European performance</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>PORTFOLIO INVESTMENTS - Co invested $314.8 mln in nonperforming loan portfolios in Q4, contributing to cash collection growth</span></p></li></ul><p class=\"\"><span>Company press release: </span></p><p class=\"\"><span>Key Details</span></p><div class=\"tableContainer-VG8_37yK\"><table class=\"table-VG8_37yK\" data-no-swipe=\"true\"><tbody><tr><td><p class=\"\"><span>Metric</span></p></td><td><p class=\"\"><span>Beat/Miss</span></p></td><td><p class=\"\"><span>Actual</span></p></td><td><p class=\"\"><span>Consensus Estimate</span></p></td></tr><tr><td><p class=\"\"><span>Q4 Net Income</span></p></td><td></td><td><p class=\"\"><span>$59.2 mln</span></p></td><td></td></tr><tr><td><p class=\"\"><span>Q4 Operating Expenses</span></p></td><td></td><td><p class=\"\"><span>$207.8 mln</span></p></td><td></td></tr></tbody></table></div><p class=\"\"><span>Analyst Coverage</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The current average analyst rating on the shares is \"hold\" and the breakdown of recommendations is 1 \"strong buy\" or \"buy\", 2 \"hold\" and no \"sell\" or \"strong sell\"</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The average consensus recommendation for the corporate financial services peer group is \"buy.\"</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Wall Street's median 12-month price target for PRA Group Inc is $26.00, about 122.2% above its February 25 closing price of $11.70</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 7 three months ago</span></p></li></ul><p class=\"\"><span>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact </span><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"http://mailto:reuters.support@thomsonreuters.com\" rel=\"nofollow\" target=\"_blank\">reuters.support@thomsonreuters.com</a><span>.</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026:newsml_L1N3ZM1HX:0-pra-group-q4-cash-collections-rise/",
            "pub_date": "2026-02-27 05:49:50",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026:newsml_L1N3ZM1H7:0",
            "title": "Castle Biosciences Q4 revenue beats expectations",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Overview</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Diagnostics company's Q4 revenue rose 1%, beating analyst expectations</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Company's core test reports increased 42% in Q4, driven by dermatologic and gastrointestinal tests</span></p></li></ul><p class=\"\"><span>Outlook</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Castle Biosciences anticipates 2026 revenue between $340 mln and $350 mln</span></p></li></ul><p class=\"\"><span>Result Drivers</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>CORE TEST GROWTH - Total test reports for DecisionDx-Melanoma and TissueCypher increased 37% over 2024, with TissueCypher reports growing 86%</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>MEDICARE COVERAGE IMPACT - Revenue affected by change in DecisionDx-SCC Medicare coverage and discontinuation of IDgenetix</span></p></li></ul><p class=\"\"><span>Company press release: </span></p><p class=\"\"><span>Key Details</span></p><div class=\"tableContainer-VG8_37yK\"><table class=\"table-VG8_37yK\" data-no-swipe=\"true\"><tbody><tr><td><p class=\"\"><span>Metric</span></p></td><td><p class=\"\"><span>Beat/Miss</span></p></td><td><p class=\"\"><span>Actual</span></p></td><td><p class=\"\"><span>Consensus Estimate</span></p></td></tr><tr><td><p class=\"\"><span>Q4 Revenue</span></p></td><td><p class=\"\"><span>Beat</span></p></td><td><p class=\"\"><span>$87.01 mln</span></p></td><td><p class=\"\"><span>$79.05 mln (7 Analysts)</span></p></td></tr><tr><td><p class=\"\"><span>Q4 Net Income</span></p></td><td></td><td><p class=\"\"><span>-$2.33 mln</span></p></td><td></td></tr><tr><td><p class=\"\"><span>Q4 Operating Expenses</span></p></td><td></td><td><p class=\"\"><span>$90.84 mln</span></p></td><td></td></tr><tr><td><p class=\"\"><span>Q4 Operating Income</span></p></td><td></td><td><p class=\"\"><span>-$3.83 mln</span></p></td><td></td></tr><tr><td><p class=\"\"><span>Q4 Pretax Profit</span></p></td><td></td><td><p class=\"\"><span>-$2.71 mln</span></p></td><td></td></tr></tbody></table></div><p class=\"\"><span>Analyst Coverage</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The current average analyst rating on the shares is \"strong buy\" and the breakdown of recommendations is 8 \"strong buy\" or \"buy\", no \"hold\" and no \"sell\" or \"strong sell\"</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The average consensus recommendation for the medical equipment, supplies &amp; distribution peer group is \"buy.\"</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Wall Street's median 12-month price target for Castle Biosciences Inc is $50.00, about 62.2% above its February 25 closing price of $30.83</span></p></li></ul><p class=\"\"><span>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact </span><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"http://mailto:reuters.support@thomsonreuters.com\" rel=\"nofollow\" target=\"_blank\">reuters.support@thomsonreuters.com</a><span>.</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026:newsml_L1N3ZM1H7:0-castle-biosciences-q4-revenue-beats-expectations/",
            "pub_date": "2026-02-27 05:50:13",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026:newsml_L1N3ZM1HW:0",
            "title": "PAR Technology beats Q4 revenue estimates; authorizes $100 mln buyback",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Overview</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Foodservice tech firm's Q4 revenue rose 14.4% yr/yr, beating analyst expectations</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Adjusted EBITDA for Q4 improved compared to last year</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Company authorized $100 mln share repurchase program</span></p></li></ul><p class=\"\"><span>Result Drivers</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>ARR GROWTH - Annual Recurring Revenue grew 16% in Q4, with organic growth contributing 15%</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>AI PLATFORM STRATEGY - CEO attributed Q4 performance to success in building a unified platform for AI</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>PRODUCT LINE EXPANSION - Engagement Cloud and Operator Cloud product lines saw notable ARR and active site growth</span></p></li></ul><p class=\"\"><span>Company press release: </span></p><p class=\"\"><span>Key Details</span></p><div class=\"tableContainer-VG8_37yK\"><table class=\"table-VG8_37yK\" data-no-swipe=\"true\"><tbody><tr><td><p class=\"\"><span>Metric</span></p></td><td><p class=\"\"><span>Q4 Revenue</span></p></td></tr><tr><td><p class=\"\"><span>Beat/Miss</span></p></td><td><p class=\"\"><span>Beat</span></p></td></tr><tr><td><p class=\"\"><span>Actual</span></p></td><td><p class=\"\"><span>$120.10 mln</span></p></td></tr><tr><td><p class=\"\"><span>Consensus Estimate</span></p></td><td><p class=\"\"><span>$116.73 mln (9 Analysts)</span></p></td></tr></tbody></table></div><p class=\"\"><span>Analyst Coverage</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 9 \"strong buy\" or \"buy\", 1 \"hold\" and no \"sell\" or \"strong sell\"</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The average consensus recommendation for the office equipment peer group is \"buy\"</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Wall Street's median 12-month price target for PAR Technology Corp is $60.00, about 188.7% above its February 25 closing price of $20.78</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The stock recently traded at 29 times the next 12-month earnings vs. a P/E of 64 three months ago</span></p></li></ul><p class=\"\"><span>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact </span><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"http://mailto:reuters.support@thomsonreuters.com\" rel=\"nofollow\" target=\"_blank\">reuters.support@thomsonreuters.com</a><span>.</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026:newsml_L1N3ZM1HW:0-par-technology-beats-q4-revenue-estimates-authorizes-100-mln-buyback/",
            "pub_date": "2026-02-27 05:50:14",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026:newsml_L1N3ZM1H1:0",
            "title": "Evertec Q4 revenue up 13.1%, beats estimates",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Overview</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Transaction processor's Q4 revenue rose 13.1%, beating analyst expectations</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Q4 net income declined to $35.6 mln, while adjusted EPS beat expectations</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Company increased share repurchase authorization to $150 mln</span></p></li></ul><p class=\"\"><span>Outlook</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Company expects 2026 revenue between $1,024 mln and $1,036 mln</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Evertec anticipates 2026 adjusted EPS between $3.84 and $3.96</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Company projects 2026 capital expenditures around $90 mln</span></p></li></ul><p class=\"\"><span>Result Drivers</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>ORGANIC GROWTH AND ACQUISITIONS - Revenue increase driven by organic growth across most segments and contributions from Tecnobank acquisition</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>MERCHANT ACQUIRING AND PAYMENTS PUERTO RICO - Revenue growth in merchant acquiring due to higher sales volume and in Payments Puerto Rico from ATH Movil transaction growth</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>COST INCREASES - Net income decline attributed to higher depreciation, amortization, and increased personnel and cloud expenses</span></p></li></ul><p class=\"\"><span>Company press release: </span></p><p class=\"\"><span>Key Details</span></p><div class=\"tableContainer-VG8_37yK\"><table class=\"table-VG8_37yK\" data-no-swipe=\"true\"><tbody><tr><td><p class=\"\"><span>Metric</span></p></td><td><p class=\"\"><span>Beat/Miss</span></p></td><td><p class=\"\"><span>Actual</span></p></td><td><p class=\"\"><span>Consensus Estimate</span></p></td></tr><tr><td><p class=\"\"><span>Q4 Revenue</span></p></td><td><p class=\"\"><span>Beat</span></p></td><td><p class=\"\"><span>$244.8 mln</span></p></td><td><p class=\"\"><span>$236.82 mln (5 Analysts)</span></p></td></tr><tr><td><p class=\"\"><span>Q4 Adjusted EPS</span></p></td><td><p class=\"\"><span>Beat</span></p></td><td><p class=\"\"><span>$0.93</span></p></td><td><p class=\"\"><span>$0.89 (6 Analysts)</span></p></td></tr><tr><td><p class=\"\"><span>Q4 Adjusted Net Income</span></p></td><td><p class=\"\"><span>Beat</span></p></td><td><p class=\"\"><span>$59.5 mln</span></p></td><td><p class=\"\"><span>$58.39 mln (5 Analysts)</span></p></td></tr><tr><td><p class=\"\"><span>Q4 Net Income</span></p></td><td></td><td><p class=\"\"><span>$35.6 mln</span></p></td><td></td></tr><tr><td><p class=\"\"><span>Q4 Adjusted EBITDA</span></p></td><td><p class=\"\"><span>Beat</span></p></td><td><p class=\"\"><span>$98.8 mln</span></p></td><td><p class=\"\"><span>$95.47 mln (5 Analysts)</span></p></td></tr></tbody></table></div><p class=\"\"><span>Analyst Coverage</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 3 \"strong buy\" or \"buy\", 3 \"hold\" and no \"sell\" or \"strong sell\"</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The average consensus recommendation for the business support services peer group is \"buy\"</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Wall Street's median 12-month price target for Evertec Inc is $32.00, about 26.5% above its February 25 closing price of $25.30</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The stock recently traded at 7 times the next 12-month earnings vs. a P/E of 8 three months ago</span></p></li></ul><p class=\"\"><span>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact </span><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"http://mailto:reuters.support@thomsonreuters.com\" rel=\"nofollow\" target=\"_blank\">reuters.support@thomsonreuters.com</a><span>.</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026:newsml_L1N3ZM1H1:0-evertec-q4-revenue-up-13-1-beats-estimates/",
            "pub_date": "2026-02-27 05:50:16",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026:newsml_L1N3ZM1H4:0",
            "title": "Definitive Healthcare beats Q4 revenue expectationsÂ ",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Overview</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Healthcare data firm's Q4 revenue decreased 1% yr/yr, beating analyst expectations</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Net loss for Q4 reduced significantly due to lower goodwill impairment charges</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Adjusted EBITDA for Q4 improved slightly in margin compared to last year</span></p></li></ul><p class=\"\"><span>Outlook</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Company expects Q1 2026 revenue between $54.0 mln and $56.0 mln</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Definitive Healthcare forecasts full-year 2026 revenue between $220.0 mln and $226.0 mln</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Company aims to improve retention rates and increase upsell and cross-sell activity</span></p></li></ul><p class=\"\"><span>Result Drivers</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>CUSTOMER EXPANSION - Definitive Healthcare secured new contracts with a large nonprofit health system and a global leader in therapy solutions, aiding market expansion</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>STRATEGIC FOCUS - CEO Kevin Coop emphasized focus on improving retention rates and increasing upsell and cross-sell activity</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>INTEGRATION CAPABILITIES - Seamless integration capabilities were critical in securing contracts, allowing efficient data management and customer success</span></p></li></ul><p class=\"\"><span>Company press release: </span></p><p class=\"\"><span>Key Details</span></p><div class=\"tableContainer-VG8_37yK\"><table class=\"table-VG8_37yK\" data-no-swipe=\"true\"><tbody><tr><td><p class=\"\"><span>Metric</span></p></td><td><p class=\"\"><span>Beat/Miss</span></p></td><td><p class=\"\"><span>Actual</span></p></td><td><p class=\"\"><span>Consensus Estimate</span></p></td></tr><tr><td><p class=\"\"><span>Q4 Revenue</span></p></td><td><p class=\"\"><span>Beat</span></p></td><td><p class=\"\"><span>$61.53 mln</span></p></td><td><p class=\"\"><span>$59.57 mln (9 Analysts)</span></p></td></tr><tr><td><p class=\"\"><span>Q4 Net Income</span></p></td><td></td><td><p class=\"\"><span>-$17.15 mln</span></p></td><td></td></tr><tr><td><p class=\"\"><span>Q4 Gross Profit</span></p></td><td></td><td><p class=\"\"><span>$46.91 mln</span></p></td><td></td></tr><tr><td><p class=\"\"><span>Q4 Pretax Profit</span></p></td><td></td><td><p class=\"\"><span>-$17.20 mln</span></p></td><td></td></tr></tbody></table></div><p class=\"\"><span>Analyst Coverage</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The current average analyst rating on the shares is \"hold\" and the breakdown of recommendations is 3 \"strong buy\" or \"buy\", 8 \"hold\" and 1 \"sell\" or \"strong sell\"</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The average consensus recommendation for the software peer group is \"buy.\"</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>Wall Street's median 12-month price target for Definitive Healthcare Corp is $3.75, about 166% above its February 25 closing price of $1.41</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>The stock recently traded at 5 times the next 12-month earnings vs. a P/E of 11 three months ago</span></p></li></ul><p class=\"\"><span>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact </span><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"http://mailto:reuters.support@thomsonreuters.com\" rel=\"nofollow\" target=\"_blank\">reuters.support@thomsonreuters.com</a><span>.</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026:newsml_L1N3ZM1H4:0-definitive-healthcare-beats-q4-revenue-expectations/",
            "pub_date": "2026-02-27 05:50:18",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026:newsml_L1N3ZM1GY:0",
            "title": "Trump administration cannot force states to supply food stamp data, US judge rules",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div><span><p class=\"\"><span>By Nate Raymond</span></p><p class=\"\"><span>    A federal judge on Thursday blocked President </span><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"https://www.reuters.com/world/us/donald-trump/\" rel=\"nofollow\" target=\"_blank\">Donald Trump's</a><span> administration from cutting off funding for 22 Democratic-led states to administer food stamp benefits unless they turned over data on millions of people who received the aid.</span></p><p class=\"\"><span>U.S. District Judge Maxine Chesney in San Francisco issued a </span><a class=\"link-zw5jRdec icon-zw5jRdec\" href=\"https://fingfx.thomsonreuters.com/gfx/legaldocs/gkvlkggegpb/snap_ruling.pdf\" rel=\"nofollow\" target=\"_blank\">preliminary injunction</a><span> barring the U.S. Department of Agriculture from halting funding based on demands it made in recent months for the states to supply data on recipients of Supplemental Nutrition Assistance Program benefits.</span></p><p class=\"\"><span>State attorneys general had asked the judge to block USDA from doing so, saying it was threatening to cut off administrative funding for the program despite an earlier ruling by Chesney preventing it from stripping them of funding for SNAP.</span></p><p class=\"\"><span>The USDA in letters sent to the states in November and December had renewed its demands for information including the names, addresses and immigration status of individuals in those states who sought aid through the government's food aid program for low-income people.</span></p><p class=\"\"><span>About 42 million people receive benefits from SNAP, which is largely funded by the federal government and administered by states. Immigrants who are in the United States illegally are not eligible for SNAP.</span></p><p class=\"\"><span>The agency said it needed the data to fulfill the administration's goal of eliminating waste, fraud and abuse in government assistance programs and had established new protocols to secure the data.</span></p><p class=\"\"><span>But Chesney, an appointee of Democratic President Bill Clinton, said the USDA's demands for data and threats to cut off funding appeared contrary to the law governing SNAP, and that the agency's protocols would allow it to improperly share data with unauthorized entities.</span></p><p class=\"\"><span>USDA did not respond to a request for comment.</span></p><p class=\"\"><span>Twenty-eight states, largely led by Republicans, have so far submitted the data the USDA sought, according to a November letter from the agency.</span></p><p class=\"\"><span>Among the states that challenged the USDA's demand were California, New York and Arizona. </span></p><p class=\"\"><span>New York Attorney General Letitia James in a social media post said Thursday's ruling would protect SNAP data \"for millions of vulnerable people and our immigrant communities.\"</span></p></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026:newsml_L1N3ZM1GY:0-trump-administration-cannot-force-states-to-supply-food-stamp-data-us-judge-rules/",
            "pub_date": "2026-02-27 05:44:39",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "urn:summary_document_report:quartr.com:2939603:0",
            "title": "Diversified Energy Company: Credit agreement amended to reaffirm $900M borrowing base and add $500M Nordic Bond Facility",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div><span><p class=\"\"><span>The company amended its credit agreement on May 22, 2025, reaffirming a $900 million borrowing base and replacing the seller facility with a $500 million Nordic Bond Facility. The amendment allows for share repurchases from employees, updates reporting deadlines, and maintains strong lender support and liquidity.</span></p><p class=\"\"><span>Original document: </span><a class=\"link-zw5jRdec\" href=\"https://www.tradingview.com/accounts/signin?next=https%3A%2F%2Fnews-mediator.tradingview.com%2Fdoc-screener%2Fv1%2Ffiles%2Furn%3Areport%3Aquartr.com%3A2939603-e5b88aed124dbbc523ee389cf9452851\" target=\"_blank\">Diversified Energy Company SEC 10-K Annual Report â€” Feb. 27 2026</a></p><section class=\"variant-secondary-aHOVUrmQ disclaimer-fdvjGD1u\"><b class=\"heading-wrapper-aHOVUrmQ\"><span class=\"heading-aHOVUrmQ\">Disclaimer</span></b><div class=\"content-aHOVUrmQ link-with-underline-aHOVUrmQ\"><span>This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.</span></div></section></span></div></div>",
            "link": "https://www.tradingview.com/news/urn:summary_document_report:quartr.com:2939603:0-diversified-energy-company-credit-agreement-amended-to-reaffirm-900m-borrowing-base-and-add-500m-nordic-bond-facility/",
            "pub_date": "2026-02-27 05:44:39",
            "source": "Quartr",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "tag:reuters.com,2026:newsml_FWN3ZM245:0",
            "title": "Coles Group Says In First 7 Weeks Of Q3, Supermarkets Sales Revenue Increased By 3.7%",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Coles Group Ltd </span><span>:</span></p><ul class=\"list-bmN0_SHH list--padded-bmN0_SHH\"><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>IN FIRST SEVEN WEEKS OF Q3, SUPERMARKETS SALES REVENUE INCREASED BY 3.7%</span></p></li><li class=\"listItem-bmN0_SHH\"><p class=\"\"><span>EXPECT MARKET TO REMAIN HIGHLY COMPETITIVE</span></p></li></ul></span></div></div>",
            "link": "https://www.tradingview.com/news/reuters.com,2026:newsml_FWN3ZM245:0-coles-group-says-in-first-7-weeks-of-q3-supermarkets-sales-revenue-increased-by-3-7/",
            "pub_date": "2026-02-27 05:44:40",
            "source": "Reuters",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "urn:summary_document_report:quartr.com:2939614:0",
            "title": "MTZ: Revenue up 16% to $14.3B, net income more than doubled, backlog hit $19B, and five acquisitions closed",
            "description": "<div class=\"body-KX2tCBZq body-nzzZVyQ3 content-nzzZVyQ3\"><div class=\"symbolsContainer-uFduEtAF logosContainer-diQOvrPB\" data-no-swipe=\"true\"></div><div><span><p class=\"\"><span>Revenue grew 16% to $14.3B with net income up 112% to $422M, driven by double-digit growth in most segments and a record $19B backlog. The company completed five acquisitions, expanded its service offerings, and maintained strong liquidity, but faces risks from policy changes, inflation, and supply chain disruptions.</span></p><p class=\"\"><span>Original document: </span><a class=\"link-zw5jRdec\" href=\"https://www.tradingview.com/accounts/signin?next=https%3A%2F%2Fnews-mediator.tradingview.com%2Fdoc-screener%2Fv1%2Ffiles%2Furn%3Areport%3Aquartr.com%3A2939614-1f1f37544704c9bd9f5710470f330f71\" target=\"_blank\">MasTec, Inc. [MTZ] SEC 10-K Annual Report â€” Feb. 27 2026</a></p><section class=\"variant-secondary-aHOVUrmQ disclaimer-fdvjGD1u\"><b class=\"heading-wrapper-aHOVUrmQ\"><span class=\"heading-aHOVUrmQ\">Disclaimer</span></b><div class=\"content-aHOVUrmQ link-with-underline-aHOVUrmQ\"><span>This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.</span></div></section></span></div></div>",
            "link": "https://www.tradingview.com/news/urn:summary_document_report:quartr.com:2939614:0-mtz-revenue-up-16-to-14-3b-net-income-more-than-doubled-backlog-hit-19b-and-five-acquisitions-closed/",
            "pub_date": "2026-02-27 05:44:42",
            "source": "Quartr",
            "kind": 1,
            "language": "en"
        }
    ]
}